~~<i id='BE93C9DA07'><strike id='BE93C9DA07'><tt id='BE93C9DA07'><pre id='BE93C9DA07'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：hotspot 2025-10-01 23:08:05 - browse：4

Pharmacy shelves — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Physician assistants need a new name. Here's what it should be

focus

explore

Wikipedia

focus

AdobeMedicareAdvantageisarguablythemostcontroversialhealthcareprogramrightnow—asentimentthatwasbolst

WSS

Amylyx ALS drug failure raises questions and concerns

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Change Healthcare cyberattack prompts Medicare loan program

NEJM study link tiny plastics in blood vessels to heart problems

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Male doctors called my cancer incurable. A female doctor showed it wasn't

focus

comprehensive

focus

Apple is now the first public company to be valued at $3 trillion

In his State of the Union, Biden takes clear aim at 'Big Pharma'

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Walensky prepares to leave CDC — and Congress — behind

Medicare Advantage coverage denials need scrutiny, senators say

How to save PrEP access — and even expand it

With psoriasis trial ahead, Alumis raises $259 million

Medical records are filled with copy

Ascension's ugly legal battle over care for poor patients in Texas

focus

Life science postdocs should get big pay hike, NIH panel says

Change Healthcare cyberattack prompts Medicare loan program

The Readout: Amylyx, Alumis, and Lundbeck drug updates

FDA early review: GLP

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Boston Scientific acquires urology company Axonics for $3.7 billion

explore

Wikipedia

focus

focus